Sheng‐Wei Yang - Concepedia

Author

Sheng‐Wei Yang

Also Known As

Sheng-Wei Yang, Shengwei Yang, Sheng‐Wei Yang

Publications

169

Citations

H-Index

Concepts

All Affiliations

Sheng‐Wei Yang is an author at China Pharmaceutical University specializing in medicine, pharmacology, and medicinal chemistry.

#	Concept	H-Index	Publications	Citations
1	Medicine	3	3	99
2	Engineering	2	2	44
3	Biochemistry	2	2	70
4	Natural Sciences	1	1	49
5	Biomedical Engineering	1	1	29

Sheng‐Wei Yang

Publications

126

Citations

H-Index

Page 1

	Year	Citations
Fluoroketone Inhibition of Ca<sup>2+</sup>-Independent Phospholipase A<sub>2</sub> through Binding Pocket Association Defined by Hydrogen/Deuterium Exchange and Molecular Dynamics Yuan‐Hao Hsu, Denis Bucher, Jian Cao, Journal of the American Chemical Society Proteinlipid InteractionMolecular BiologyAnalytical UltracentrifugationChemical BiologyMolecular Dynamics	2012	49
Discovery of Radioiodinated Monomeric Anthraquinones as a Novel Class of Necrosis Avid Agents for Early Imaging of Necrotic Myocardium Qin Wang, Sheng‐Wei Yang, Cuihua Jiang, Scientific Reports Early ImagingEngineeringImaging AgentPathologyBiomedical Engineering	2016	29
Synthesis and Preclinical Evaluation of Radioiodinated Hypericin Dicarboxylic Acid as a Necrosis Avid Agent in Rat Models of Induced Hepatic, Muscular, and Myocardial Necroses Jindian Li, Jian Zhang, Sheng‐Wei Yang, Molecular Pharmaceutics InflammationMyocardium ViabilityBiochemistryCardiovascular DiseaseMedicine	2015	21
Palladium-catalyzed oxidative C–H/C–H cross-couplings of thiazolo[5,4-d]pyrimidine with aromatic (hetero)cycles Sheng‐Wei Yang, Ye‐Xiang Su, Li‐Ping Sun Tetrahedron Cross-coupling ReactionEngineeringOrganic ChemistryOrganometallic CatalysisCatalysis	2014	15
Synthesis and Evaluation of <sup>131</sup>I-Skyrin as a Necrosis Avid Agent for Potential Targeted Radionuclide Therapy of Solid Tumors Cong Wang, Qiaomei Jin, Sheng‐Wei Yang, Molecular Pharmaceutics	2015	12

Page 1